Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Molecular Partners logo — Pioneering DARPin Therapeutics for Patients

Molecular Partners

Pioneering DARPin Therapeutics for Patients

Founded 2004 Switzerland Switzerland 174 employees Post Ipo Equity Total: $179.96M Biotechnology, Pharmaceutical

General Information

Company Name Molecular Partners
Founded Year 2004
Location Switzerland Switzerland +2
Founders / Decision Makers
Team member Team member
Employees 174
Industries Biotechnology, Pharmaceutical
Funding Stage Post Ipo Equity
Social

Get notified when Molecular Partners moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Molecular Partners

Molecular Partners is a clinical-stage biotech company founded in 2004 and headquartered in Switzerland. The company specializes in pioneering DARPin therapeutics, which represent a new class of custom-built drugs aimed at addressing medical challenges that are difficult for other modalities to tackle. With a primary focus on oncology, Molecular Partners has several programs in various stages of pre-clinical and clinical development. The company leverages the advantages of DARPins to offer unique solutions to patients through its proprietary programs and partnerships with leading pharmaceutical companies. Notably, Molecular Partners received a Fr.40.00M Post-IPO Equity investment on 28 October 2020, with the investment coming from Novartis. This demonstrates confidence from a major player in the pharmaceutical industry and highlights the potential of Molecular Partners as a significant player in the biotech and pharmaceutical industries.

Taxonomy: biotech, DARPin therapeutics, clinical-stage, oncology, virology, pharmaceutical research, biopharmaceutical, small protein therapies, intellectual property, immunology, ophthalmology, collaborations, serious diseases, top biotech investors

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• 1
Investor
28 Oct 2020
Post-IPO Equity •••••• 4
Investor Investor
•••• •••• 		06 Jul 2020
Series B •••••• 5
Investor Investor Investor Investor
•••• •••• 		16 Dec 2009
Series A •••••• - 14 Aug 2007

Molecular Partners Alternatives & Competitors

Molecular Partners vs
Caliper Life Sciences
Caliper Life Sciences

Caliper, A PerkinElmer Company, is a research tools company engaged in the sale of innovative and en...

Seed
148 employees
Biotechnology, Pharmaceutical
Compare Molecular Partners vs Caliper Life Sciences
Molecular Partners vs
Julius Clinical
Julius Clinical The Netherlands

Julius Clinical manages global clinical drug trials that will have a major impact on medicine and ma...

Private Equity
176 employees
Health Care, Pharmaceutical
Compare Molecular Partners vs Julius Clinical
Molecular Partners vs
Transgenomic
Transgenomic United States

Transgenomic, Inc. (www.transgenomic.com) is a global biotechnology company advancing personalized m...

42 employees
Also compare with: Molecular Partners vs Innorna Innorna

FAQ About Molecular Partners

Pioneering DARPin Therapeutics for Patients
Molecular Partners was founded in 2004.
Molecular Partners is headquartered in Switzerland.
Molecular Partners operates in the following industries: Biotechnology, Pharmaceutical.
Molecular Partners has approximately 174 employees.
Molecular Partners has completed 4 funding rounds, raising a total of $179.96M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Molecular Partners include Caliper Life Sciences, Julius Clinical, Transgenomic, betaSENSE, GangaGen Biotechnologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Molecular Partners and Caliper Life Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Molecular Partners and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy